HomeKPTI • NASDAQ
add
Karyopharm Therapeutics Inc
Previous close
$0.71
Day range
$0.69 - $0.73
Year range
$0.62 - $1.95
Market cap
89.81M USD
Avg Volume
528.49K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 42.79M | 13.86% |
Operating expense | 31.07M | -9.89% |
Net income | 23.79M | 172.91% |
Net profit margin | 55.61 | 164.04% |
Earnings per share | -0.29 | 0.17% |
EBITDA | -28.03M | 4.95% |
Effective tax rate | 0.28% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 152.12M | -35.75% |
Total assets | 213.98M | -28.15% |
Total liabilities | 346.12M | -6.22% |
Total equity | -132.14M | — |
Shares outstanding | 124.68M | — |
Price to book | -0.67 | — |
Return on assets | -33.60% | — |
Return on capital | -50.77% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 23.79M | 172.91% |
Cash from operations | -38.50M | -49.81% |
Cash from investing | 51.26M | 142.14% |
Cash from financing | 40.97M | 4,663.49% |
Net change in cash | 53.72M | 1,554.22% |
Free cash flow | -30.74M | -105.52% |
About
Founded
2008
Headquarters
Website
Employees
325